Safeguard Scientifics (SFE) Rating Lowered to Hold at Zacks Investment Research

Safeguard Scientifics (NYSE:SFE) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday.

According to Zacks, “Safeguard Scientifics, Inc. is a diversified information technology company that develops, operates and manages emerging growth information technology companies. The company is currently focusing on emerging opportunities in eCommerce, enterprise applications, and network infrastructure, all of which are expected to benefit from the growing use of the Internet as a fundamental business tool. The company works closely with our partnership companies to provide numerous operational and management services to build value in preparation for public rights offerings and beyond. “

How to Become a New Pot Stock Millionaire

SFE has been the topic of a number of other research reports. Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $14.50 price target on shares of Safeguard Scientifics in a report on Thursday, March 1st. Barrington Research reiterated a “buy” rating and issued a $20.00 price target on shares of Safeguard Scientifics in a report on Tuesday, March 6th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $16.17.

SFE stock opened at $12.40 on Thursday. The company has a market capitalization of $256.05, a price-to-earnings ratio of -2.86 and a beta of 1.27. The company has a debt-to-equity ratio of 0.55, a current ratio of 0.73 and a quick ratio of 0.73. Safeguard Scientifics has a one year low of $10.65 and a one year high of $14.40.

Safeguard Scientifics (NYSE:SFE) last released its earnings results on Thursday, March 1st. The asset manager reported ($0.91) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($1.05) by $0.14. During the same quarter in the previous year, the firm earned ($1.07) earnings per share. sell-side analysts expect that Safeguard Scientifics will post -3.23 EPS for the current year.

Several institutional investors and hedge funds have recently made changes to their positions in SFE. Ariel Investments LLC boosted its holdings in shares of Safeguard Scientifics by 18.7% in the 4th quarter. Ariel Investments LLC now owns 1,501,367 shares of the asset manager’s stock valued at $16,815,000 after purchasing an additional 236,758 shares during the last quarter. Deutsche Bank AG lifted its holdings in shares of Safeguard Scientifics by 27.1% during the 4th quarter. Deutsche Bank AG now owns 534,475 shares of the asset manager’s stock valued at $5,984,000 after acquiring an additional 114,125 shares in the last quarter. Granahan Investment Management Inc. MA lifted its holdings in shares of Safeguard Scientifics by 20.8% during the 3rd quarter. Granahan Investment Management Inc. MA now owns 646,492 shares of the asset manager’s stock valued at $8,631,000 after acquiring an additional 111,370 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Safeguard Scientifics by 42.5% during the 4th quarter. Renaissance Technologies LLC now owns 309,417 shares of the asset manager’s stock valued at $3,465,000 after acquiring an additional 92,300 shares in the last quarter. Finally, Bank of Montreal Can lifted its holdings in shares of Safeguard Scientifics by 10.7% during the 4th quarter. Bank of Montreal Can now owns 606,520 shares of the asset manager’s stock valued at $6,793,000 after acquiring an additional 58,498 shares in the last quarter. Institutional investors own 76.54% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/3337448/safeguard-scientifics-sfe-rating-lowered-to-hold-at-zacks-investment-research.html.

About Safeguard Scientifics

Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings in Fintech sector. It initially invests in a Series A-C round and opportunistically in a seed round.

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Millennium Management LLC Buys 99,325 Shares of Hospital Co. of America
Millennium Management LLC Buys 99,325 Shares of Hospital Co. of America
MetLife Investment Advisors LLC Invests $1.24 Million in JELD-WEN Holding, Inc.
MetLife Investment Advisors LLC Invests $1.24 Million in JELD-WEN Holding, Inc.
Analysts Expect EntreMed, Inc.  to Post -$0.07 EPS
Analysts Expect EntreMed, Inc. to Post -$0.07 EPS
Meridian Wealth Management LLC Has $1.04 Million Position in Alphabet Inc.
Meridian Wealth Management LLC Has $1.04 Million Position in Alphabet Inc.
LPL Financial LLC Has $1.07 Million Stake in Rydex S&P SmallCap 600 Pure Value ETF
LPL Financial LLC Has $1.07 Million Stake in Rydex S&P SmallCap 600 Pure Value ETF
LPL Financial LLC Has $1.08 Million Holdings in PIMCO Income Strategy
LPL Financial LLC Has $1.08 Million Holdings in PIMCO Income Strategy


Leave a Reply

© 2006-2018 Ticker Report. Google+.